ArticleJapanese journal of clinical oncology2020
Phase I trial of the MET inhibitor tepotinib in Japanese patients with solid tumors.
Kohei Shitara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this paperpooled ittrialcites it